Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens

14 Jul 2022

Abstract excerpt

The SARS-CoV-2 pandemic prompted a global vaccination effort and the development of numerous COVID-19 vaccines at an unprecedented scale and pace. As a result, current COVID-19 vaccination regimens comprise diverse vaccine modalities, immunogen combinations, and dosing intervals. Here, we compare vaccine-specific antibody and memory B cell responses following two-dose mRNA, single-dose Ad26.COV.2S, and two-dose...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36006380
DOI: 10.1084/jem.20220826

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimensPMID 36006380Read ↗

Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Semantic proximity Read ↗

mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variantsSemantic proximity Read ↗

Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccineSemantic proximity Read ↗

Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humansSemantic proximity Read ↗

Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccinationSemantic proximity Read ↗

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccinesSemantic proximity Read ↗

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernSemantic proximity Read ↗

Waning and boosting of functional humoral immunity to SARS-CoV-2Semantic proximity Read ↗

T Cell Responses to SARS-CoV-2Semantic proximity Read ↗

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsSemantic proximity Read ↗

Resilient Fc-Effector Functions Across SARS-CoV-2 Variants of Concern Following mRNA-1273 VaccinationSemantic proximity Read ↗

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccinationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.